# Episode 497: Reflections on the capivasertib ODAC

Page: https://stenobird.com/podcast/the-uromigos-1214845/episode-497-reflections-on-the-capivasertib-odac
Text version: https://stenobird.com/podcast/the-uromigos-1214845/episode-497-reflections-on-the-capivasertib-odac.md
Podcast: [The Uromigos](https://stenobird.com/podcast/the-uromigos-1214845)
Published: 2026-05-01T21:52:50+00:00
Episode link: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-497-Reflections-on-the-capivasertib-ODAC-e3ip0uq
Audio file: https://anchor.fm/s/13347ea8/podcast/play/119357850/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-1%2F423296441-44100-2-b41921c85ea58.m4a
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-497-reflections-on-the-capivasertib-odac
Duration seconds: 1275

## Resource

This podcast features a detailed discussion on the recent ODAC meeting, focusing on the evaluation of capivasertib, an AKT inhibitor in metastatic hormone-sensitive prostate cancer. Experts analyze trial data, benefit-risk considerations, biomarker challenges, and regulatory perspectives.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-497-reflections-on-the-capivasertib-odac/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-uromigos-1214845/episode-497-reflections-on-the-capivasertib-odac.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.